<DOC>
	<DOCNO>NCT00002747</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . It yet know surgery plus radiation therapy effective without chemotherapy treat mouth cancer . PURPOSE : Randomized phase III trial compare effectiveness surgery radiation therapy without chemotherapy treat patient stage II , stage III , stage IV mouth cancer .</brief_summary>
	<brief_title>Surgery Radiation Therapy With Without Chemotherapy Treating Patients With Mouth Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess short- long-term local control rate , disease-free survival , overall survival follow treatment neoadjuvant cisplatin plus fluorouracil follow surgery without radiotherapy v surgery alone without radiotherapy patient previously untreated stage II-IV squamous cell carcinoma oral cavity . II . Assess prognostic significance clinical pathologic response neoadjuvant chemotherapy patient . III . Compare short- long-term toxic effect two regimen . OUTLINE : This randomize , multicenter study . Patients stratify center nodal status ( N0 vs N1-2 v N3 ) . Patients randomize one two treatment arm . Arm I : Patients receive cisplatin IV day 1 fluorouracil IV continuously day 1-5 . Treatment repeat every 3 week 2 course absence disease progression unacceptable toxicity . Patients stable disease 2 course progressive disease time proceed surgery . Patients undergo resection primary tumor site possible nodal dissection sooner 2 week completion chemotherapy . Patients undergo radiotherapy 5-6 week later 8 week surgery . Arm II : Patients undergo surgery radiotherapy arm I . Patients follow every 3 month 1 year , every 6 month 2 year , yearly thereafter . PROJECTED ACCRUAL : A total 240 patient accrue study 9 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Squamous cell carcinoma lower oral cavity eligible resection T2 ( great 3 cm ) , T3 , T4 , N03 M0 ( UICC stag system ) No requirement postsurgical reconstruction would impede radiotherapy PATIENT CHARACTERISTICS : Age : 70 Performance status : WHO 0 1 Hematopoietic : WBC least 3,500/mm3 Absolute neutrophil count least 2,000/mm3 Platelet count least 110,000/mm3 Hepatic : Not specify Renal : Creatinine great 1.3 mg/dL Creatinine clearance least 50 mg/mL BUN great 50 mg/dL Cardiovascular : No cardiopathy Other : No significant internal disease No prior malignancy except basal cell carcinoma skin No geographic barrier treatment PRIOR CONCURRENT THERAPY : No prior therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
</DOC>